Literature DB >> 21691454

Progress in the Prospective Study of the Schizophrenia Prodrome.

Emery J Fu1, Kristin S Cadenhead.   

Abstract

Further understanding of the schizophrenia spectrum has helped to define the prodrome of the illness, leading to hopes of earlier identification and intervention in susceptible, at-risk individuals. Given the heterogeneity and comorbidity observed in the clinically and demographically identified prodromal sample, it is essential that neurobiological markers that are more closely linked to brain function, and perhaps the ability to predict evolution of psychosis, be identified. Ultimately, it may be possible to identify an algorithm of risk factors that will combine clinical and demographic risk factors with vulnerability markers associated with later development of schizophrenia to better target at-risk individuals or preventative treatment.

Entities:  

Year:  2005        PMID: 21691454      PMCID: PMC3117596          DOI: 10.1007/BF02629450

Source DB:  PubMed          Journal:  Curr Psychos Ther Rep        ISSN: 1545-8091


  48 in total

1.  Hippocampal and anterior cingulate morphology in subjects at ultra-high-risk for psychosis: the role of family history of psychotic illness.

Authors:  Stephen J Wood; Murat Yücel; Dennis Velakoulis; Lisa J Phillips; Alison R Yung; Warrick Brewer; Patrick D McGorry; Christos Pantelis
Journal:  Schizophr Res       Date:  2005-06-15       Impact factor: 4.939

2.  Comments on risk for schizophrenia.

Authors:  Mark Weiser; Michael Davidson; Shlomo Noy
Journal:  Schizophr Res       Date:  2005-06-17       Impact factor: 4.939

Review 3.  How does studying schizotypal personality disorder inform us about the prodrome of schizophrenia?

Authors:  Katherine Seeber; Kristin S Cadenhead
Journal:  Curr Psychiatry Rep       Date:  2005-03       Impact factor: 5.285

Review 4.  From neuropathology to neurodevelopment.

Authors:  D R Weinberger
Journal:  Lancet       Date:  1995-08-26       Impact factor: 79.321

5.  Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents.

Authors:  M Davidson; A Reichenberg; J Rabinowitz; M Weiser; Z Kaplan; M Mark
Journal:  Am J Psychiatry       Date:  1999-09       Impact factor: 18.112

6.  Diagnosing schizophrenia in the initial prodromal phase.

Authors:  J Klosterkötter; M Hellmich; E M Steinmeyer; F Schultze-Lutter
Journal:  Arch Gen Psychiatry       Date:  2001-02

7.  Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome.

Authors:  Scott W Woods; Alan Breier; Robert B Zipursky; Diana O Perkins; Jean Addington; Tandy J Miller; Keith A Hawkins; Eva Marquez; Stacy R Lindborg; Mauricio Tohen; Thomas H McGlashan
Journal:  Biol Psychiatry       Date:  2003-08-15       Impact factor: 13.382

8.  Mismatch negativity in chronic schizophrenia and first-episode schizophrenia.

Authors:  Dean F Salisbury; Martha E Shenton; Carlye B Griggs; Aaron Bonner-Jackson; Robert W McCarley
Journal:  Arch Gen Psychiatry       Date:  2002-08

9.  P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia.

Authors:  Marina Myles-Worsley; Lisa Ord; Francisca Blailes; Hilda Ngiralmau; Robert Freedman
Journal:  Biol Psychiatry       Date:  2004-04-01       Impact factor: 13.382

Review 10.  Interpreting the association between cannabis use and increased risk for schizophrenia.

Authors:  Mark Weiser; Shlomo Noy
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.